St Andrew's At Francis Place | |
300 Forby Road, Eureka, Missouri 63025 | |
(636) 938-5151 | |
Name | St Andrew's At Francis Place |
---|---|
Location | 300 Forby Road, Eureka, Missouri |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 106 |
Occupancy Rate | 79.62% |
Medicare ID (CCN) | 265195 |
Legal Business Name | St Andrews At Francis Place |
Ownership Type | Non Profit - Church Related |
NPI Number | 1720012347 |
Organization Name | ST. ANDREW'S AT FRANCIS PLACE |
Doing Business As | ST. ANDREW'S AT FRANCIS PLACE |
Address | 300 Forby Road, Eureka, MO 63025 |
Phone Number | 636-938-5151 |
News Archive
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases.
Titan Medical Inc. is pleased to announce that it has completed its private placement offering resulting in the issue of 5,822,000 units for gross proceeds of $2,328,800.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
Neuroscientists at the California Institute of Technology (Caltech) have conducted the most comprehensive brain mapping to date of the cognitive abilities measured by the Wechsler Adult Intelligence Scale (WAIS), the most widely used intelligence test in the world.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases.
Titan Medical Inc. is pleased to announce that it has completed its private placement offering resulting in the issue of 5,822,000 units for gross proceeds of $2,328,800.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
Neuroscientists at the California Institute of Technology (Caltech) have conducted the most comprehensive brain mapping to date of the cognitive abilities measured by the Wechsler Adult Intelligence Scale (WAIS), the most widely used intelligence test in the world.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 25.09 | 14.46 |
Percentage of long-stay residents who lose too much weight | 1.79 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 22.83 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.69 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.81 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.79 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 7.41 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 84.88 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 12.5 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 49.73 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.17 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 36.66 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 23.32 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.44 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.27 | 95.98 |
Percentage of short-stay residents who made improvements in function | 81.72 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 48.65 | 82.93 |
News Archive
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases.
Titan Medical Inc. is pleased to announce that it has completed its private placement offering resulting in the issue of 5,822,000 units for gross proceeds of $2,328,800.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
Neuroscientists at the California Institute of Technology (Caltech) have conducted the most comprehensive brain mapping to date of the cognitive abilities measured by the Wechsler Adult Intelligence Scale (WAIS), the most widely used intelligence test in the world.
› Verified 3 days ago